A study published in Circulation showed that the Apple Watch’s ECG detected some arrhythmias other than atrial fibrillation. The device is currently cleared to take ECGs and general irregular pulse alerts, which could indicate potential cases of atrial fibrillation.
AliveCor's at-home EKG device won FDA clearance to calculate a heart's QT interval, a measurement of how long it takes the ventricles to contract and relax. This is vital given that some drugs can lead to QT prolongation, which can increase the risk of certain arrhythmias.
The future looks bright for the integrated specialty pharmacy model – for health systems, providers, and most importantly, for patients.
Fitbit launched a large-scale study to validate the use of its technology to detect atrial fibrillation. The company plans to enroll hundreds of thousands of people into the virtual study.
In a newly published study, the researchers reported that their new digital approach yielded more accurate predictions of future arrhythmic events than current blood pumping measurements.
With the recent development of leadless pacemakers, there is optimism that complication rates may be reduced in patients with implanted pacemakers.
Despite all our tricks of medical deduction, sometimes a death can just be left unexplained: No heart attack, no stroke, no slip of a cyanide pill…The post-mortem yields nothing, and families are left without closure. Researchers over at Scripps Translational Science Institute in San Diego, led by renowned cardiologist and geneticist Eric Topol, have begun a study to help families […]
As technology advances, AI-powered tools will increasingly reduce the administrative burdens on healthcare providers.